Exhibit 99.1
FOR
IMMEDIATE RELEASE
NATURE’S SUNSHINE PRODUCTS REPORTS CHANGE IN EXECUTIVE OFFICERS
Efrain Villalobos appointed as Executive Vice President — U.S. Sales;
Craig Dalley promoted to Vice President
Greg Halliday steps down as President — U.S. Sales
PROVO,
UTAH, October 14, 2010 — Nature’s Sunshine Products, Inc.
(NASDAQ:NATR), a leading manufacturer and marketer of encapsulated herbs and
vitamins, today announced that Greg Halliday, President — U.S. Sales, has
decided to step down effective immediately.
Efrain Villalobos, Divisional Vice President — U.S. Sales, has been
appointed to Executive Vice President — U.S. Sales and will head the
division. In addition, Craig Dalley,
Divisional Vice President, was promoted to Vice President — U.S. Sales.
“I
am proud of all that we’ve accomplished at Nature’s Sunshine,” said Greg
Halliday. “My time here has been
incredibly rewarding and I have very much enjoyed my 19 years with the
Company. I will definitely miss working
with the great employees and distributors of Nature’s Sunshine Products, but
they are in good hands with Efrain.”
“Greg
has been a key member of the senior executive team and an important part of our
presence in the U.S.,” said Michael Dean, Chief Executive Officer. “I want to thank him for his service to the
Company. We all wish him well in his
future endeavors.”
Efrain
Villalobos joined Nature’s Sunshine Products in 1991 as a Field Sales
Trainer. He has served since March 2009
as Divisional Vice President — Spanish U.S. Sales with primary responsibility
over the Company’s domestic Spanish speaking sales and sales in the Dominican
Republic. Craig Dalley started at Nature’s
Sunshine Products in 1993 as a Field Sales Trainer. He later became Executive Director — U.S. Sales
and most recently served as Divisional Vice President — U.S. Sales.
Mr. Dean
commented, “Together, Efrain and Craig have 36 years of experience working with
our U.S. Sales group. They have great
relationships with our distributors and a solid understanding of what it takes
to succeed in our industry. They will be
a formidable team and
1
they
are well suited to lead our U.S. business forward and contribute to the Company’s
growth. I look forward to working with
both of these talented executives.”
About Nature’s Sunshine Products
Nature’s
Sunshine Products manufactures and markets through direct sales encapsulated
and tableted herbal products, high quality natural vitamins, and other
complementary products. In addition to the United States, the Company has
operations in Japan, Mexico, Central America, South Korea, Canada, the
Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia,
Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the
Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania,
Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden,
the Czech Republic and the Netherlands. The Company also has exclusive
distribution agreements with selected companies in Argentina, Australia, Chile,
New Zealand, and Norway. Additional information can be obtained at the Company’s
website, www.natr.com.
Cautionary Statement Regarding Forward-Looking Statements
In
addition to historical information, this release contains forward-looking
statements. Nature’s Sunshine may, from time to time, make written or oral
forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Such statements encompass Nature’s Sunshine’s
beliefs, expectations, hopes, or intentions regarding future events. Words such
as “expects,” “intends,” “believes,” “anticipates,” “should,” “likely,” and
similar expressions identify forward-looking statements. All forward-looking
statements included in this release are made as of the date hereof and are
based on information available to the Company as of such date. Nature’s
Sunshine assumes no obligation to update any forward-looking statement. Actual results will vary, and may vary materially,
from those anticipated, estimated, projected or expected for a number of
reasons, including, among others: further
reviews of the Company’s
financial statements by the Company and its Audit Committee; modification of
the Company’s accounting practices; foreign business risks; industry
cyclicality; fluctuations in customer demand and order pattern; changes in
pricing and general economic conditions; as well as other risks detailed in the
Company’s previous filings with the SEC.
Contact:
|
Stephen
M. Bunker
|
Steven
S. Anreder
|
|
Chief Financial Officer
|
Anreder & Co.
|
|
Nature’s
Sunshine Products, Inc.
|
286
Madison Avenue, Suite 907
|
|
Provo, Utah 84605-9005
|
New York, NY 10017
|
|
(801)
342-4370
|
(212)
532-3232
|
2